Related Experiment Videos
[Prognosis for patients with myocardial infarct treated with a transitory pacemaker during the 1st year]
Insights
Temporary pacemaker therapy effectively managed bradyarrhythmia in acute myocardial infarction patients. However, mortality within one year remained high, linked to infarction severity, not block type.
Area of Science:
- Cardiology
- Clinical Medicine
- Biomedical Engineering
Context:
- Acute myocardial infarction (AMI) frequently causes bradyarrhythmia and conduction disorders.
- Temporary pacemaker therapy is a common intervention for these complications.
- Long-term outcomes following pacemaker use in AMI patients require further investigation.
Purpose:
- To investigate mortality rates in AMI patients treated with temporary pacemakers.
- To analyze the relationship between conduction disorders, pacemaker therapy, and patient outcomes.
- To identify factors influencing mortality during hospitalization and the subsequent year.
Summary:
- This study followed 70 acute myocardial infarction patients receiving temporary pacemaker therapy for bradyarrhythmia.
- Mortality during hospitalization was 43%, with progression of conduction disorders observed.
- Despite successful acute-phase pacemaker therapy, one-third of patients died within one year, with mortality correlating to infarction localization and severity, not block type.
Impact:
- Findings highlight the critical role of infarction characteristics in predicting long-term survival post-AMI.
- Results underscore the need for comprehensive risk stratification beyond conduction disorders.
- This research informs clinical management strategies for AMI patients with cardiac conduction abnormalities.
Abstract:
The authors investigated the occurrence of mortality during hospitalisation (first 4 weeks) and in the following period (from the 5th week till the end of the first year) on 70 patients with acute myocardial infarction subject to temporary pacemaker therapy due to bradyarrhythmia and/or conduction disorders. Progression of conduction disorder has been commonly observed during hospitalisation, mortality amounted to 43 per cent. Almost each of the conduction disorders has been discontinued by means of prophylactic pacemaker therapy. Despite the successful pacemaker therapy during the acute phase one third of the patients died within one year. It was found by the authors that the mortality in both periods showed close relationship not with the character of the block, but with the localisation and the severity of the infarction.